Cargando…

Incidence and risk of advanced age-related macular degeneration in eyes with drusenoid pigment epithelial detachment

To investigate the incidence and risk of advanced age-related macular degeneration (AMD), including geographic atrophy (GA) and macular neovascularization (MNV), in eyes with drusenoid pigment epithelial detachment (PED). Eighty-five eyes with drusenoid PED from 85 patients (77.2 ± 7.0 years, male/f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shijo, Taiyo, Sakurada, Yoichi, Tanaka, Koji, Miki, Akiko, Sugiyama, Atsushi, Onoe, Hajime, Chubachi, Aya, Kikushima, Wataru, Wakatsuki, Yu, Yoneyama, Seigo, Mori, Ryusaburo, Kashiwagi, Kenji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8933473/ https://www.ncbi.nlm.nih.gov/pubmed/35304557 http://dx.doi.org/10.1038/s41598-022-08626-x

Ejemplares similares

Drusenoid Pigment Epithelial Detachment: Genetic and Clinical Characteristics
por: Shijo, Taiyo, et al.
Publicado: (2021)

Association between Polygenic Risk Score and One-Year Outcomes Following As-Needed Aflibercept Therapy for Exudative Age-Related Macular Degeneration
por: Shijo, Taiyo, et al.
Publicado: (2020)

Characteristics of intermediate age-related macular degeneration with hyperreflective foci
por: Kikushima, Wataru, et al.
Publicado: (2022)

Comparison of the 1-Year Visual and Anatomical Outcomes between Subthreshold Red (670 nm) and Yellow (577 nm) Micro-Pulse Laser Treatment for Diabetic Macular Edema
por: Kikushima, Wataru, et al.
Publicado: (2021)

Five-Year Outcome of Aflibercept Monotherapy for Exudative Age-Related Macular Degeneration with Good Baseline Visual Acuity
por: Kikushima, Wataru, et al.
Publicado: (2021)

Distinct characteristics of central serous chorioretinopathy according to gender
por: Yoneyama, Seigo, et al.
Publicado: (2022)

Photodynamic Therapy Treatment for Eyes with Drusenoid Pigment Epithelium Detachment
por: Lee, Na Young, et al.
Publicado: (2008)

Pachydrusen in Fellow Eyes Predict Response to Aflibercept Monotherapy in Patients with Polypoidal Choroidal Vasculopathy
por: Fukuda, Yoshiko, et al.
Publicado: (2020)

Clinical and genetic characteristics of pachydrusen in patients with exudative age-related macular degeneration
por: Fukuda, Yoshiko, et al.
Publicado: (2019)

Incidence and risk factors of retreatment after three-monthly aflibercept therapy for exudative age-related macular degeneration
por: Kikushima, Wataru, et al.
Publicado: (2017)

Genetic factors associated with response to as-needed aflibercept therapy for typical neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
por: Yoneyama, Seigo, et al.
Publicado: (2020)

Correction: Five-year outcomes of photodynamic therapy combined with intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathy
por: Kikushima, Wataru, et al.
Publicado: (2020)

Five-year outcomes of photodynamic therapy combined with intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathy
por: Wataru, Kikushima, et al.
Publicado: (2020)

Cuticular drusen presenting with central serous chorioretinopathy in both eyes: A case report
por: Hosoda, Shuhei, et al.
Publicado: (2022)

ANATOMIC AND FUNCTIONAL IMPROVEMENT OF A DRUSENOID PIGMENT EPITHELIAL DETACHMENT: A CASE REPORT
por: Csaky, Karl G., et al.
Publicado: (2020)

Prevalence and Genetic Characteristics of Geographic Atrophy among Elderly Japanese with Age-Related Macular Degeneration
por: Sakurada, Yoichi, et al.
Publicado: (2016)

Intravitreal ranibizumab for symptomatic drusenoid pigment epithelial detachment without choroidal neovascularization in age-related macular degeneration
por: Gallego-Pinazo, Roberto, et al.
Publicado: (2011)

Surgical Treatment for a Full-Thickness Macular Hole That Developed on a Large Drusenoid Pigment Epithelial Detachment
por: Azuma, Kunihiro, et al.
Publicado: (2021)

Bilateral multiple serous retinal detachments after treatment with nivolumab: a case report
por: Miyamoto, Reina, et al.
Publicado: (2020)

Comparison of two-year outcomes after photodynamic therapy with ranibizumab or aflibercept for polypoidal choroidal vasculopathy
por: Kikushima, Wataru, et al.
Publicado: (2017)

Coats plus syndrome with new observation of drusenoid retinal pigment epithelial detachments in a teenager()
por: Agrawal, Kushal U., et al.
Publicado: (2022)

Associations Between Retinal Pigment Epithelium and Drusen Volume Changes During the Lifecycle of Large Drusenoid Pigment Epithelial Detachments
por: Balaratnasingam, Chandrakumar, et al.
Publicado: (2016)

Characteristics of Grape Shelf Eye Injuries at Vineyards in Japan
por: Kikushima, Wataru, et al.
Publicado: (2022)

Laser and anti-vascular endothelial growth factor treatment for drusenoid pigment epithelial detachment in age-related macular degeneration
por: Kim, Min Seok, et al.
Publicado: (2020)

A Treat-and-Extend Regimen of Intravitreal Brolucizumab for Exudative Age-Related Macular Degeneration Refractory to Aflibercept: A 12-Month Result
por: Kikushima, Wataru, et al.
Publicado: (2023)

Autologous full-thickness RPE-choroid graft to treat high-risk drusenoid pigment epithelial detachment without CNV
por: Sillen, Hedwig, et al.
Publicado: (2020)

Comparison of Outcomes between 3 Monthly Brolucizumab and Aflibercept Injections for Polypoidal Choroidal Vasculopathy
por: Fukuda, Yoshiko, et al.
Publicado: (2021)

Morphologic Changes in Patient with Drusen and Drusenoid Pigment Epithelial Detachment after Intravitreal Ranibizumab for Choroidal Neovascular Membrane : A Case Report
por: Kim, Sukjin, et al.
Publicado: (2016)

Macular drusenoid deposits in X-linked retinoschisis
por: Tandon, Manish, et al.
Publicado: (2013)

Two-Thirds Dose Photodynamic Therapy for Pachychoroid Neovasculopathy
por: Tanaka, Koji, et al.
Publicado: (2021)

Impact of drusen and drusenoid retinal pigment epithelium elevation size and structure on the integrity of the retinal pigment epithelium layer
por: Schlanitz, Ferdinand, et al.
Publicado: (2019)

Subretinal drusenoid deposits: An update
por: Monge, Manuel, et al.
Publicado: (2022)

Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in a COVID-19 patient: A case report
por: Kogure, Chio, et al.
Publicado: (2021)

Chorioretinal thickness and retinal pigment epithelial degeneration of fellow eyes in patients with unilateral neovascular age-related macular degeneration with subretinal drusenoid deposits
por: Kang, Dongwan, et al.
Publicado: (2022)

Central serous chorioretinopathy and heart rate variability analysis with a smartphone application
por: Takeshima, Keigo, et al.
Publicado: (2020)

One-Year Outcome of Intravitreal Tissue Plasminogen Activator, Ranibizumab, and Gas Injections for Submacular Hemorrhage in Polypoidal Choroidal Vasculopathy
por: Kitagawa, Yorihisa, et al.
Publicado: (2022)

In Vivo Multimodal Imaging of Drusenoid Lesions in Rhesus Macaques
por: Yiu, Glenn, et al.
Publicado: (2017)

Subretinal drusenoid deposits versus drusen on multicolor imaging
por: Venkatesh, Ramesh, et al.
Publicado: (2020)

Clinical and Multimodal Imaging Features of Subretinal Drusenoid Deposits
por: Kumawat, Devesh, et al.
Publicado: (2021)

Assessment of macular function in patients with non-vascularized pigment epithelial detachment
por: Kitano, Marie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rcshg71iojag80o0na0ifjs47r